Homoeopathic Association in Aortic Valve Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-09-30

Study Completion Date

2007-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized, parallel group, placebo controlled study to assess the effect of an homoeopathic association of Arnica 5 CH et Bryonia 9 CH during aortic valve surgery with extra corporeal circulation, to alleviate inflammation, haemorrhage, myocardial ischemia and pain. This is a pilot study; a confirmative study will be set up if this study is positive.

The study treatment will start the day before surgery, and will comprise 5 granules of each homoeopathic medication, Arnica 5 CH and Bryonia 9 CH, or their matching placebo TID during 5 days, in addition to all routine treatments.) Two groups of 45 patients will be included. Patients have to be over 18 years, to undergo aortic valve surgery only, have no known allergy to one of the study drugs, sign a consent form, and must not have received anti inflammatory drug in the 3 days before surgery. The primary criteria include the amount of drained liquid from the chest, and the CRP evolution from baseline to the 7th postoperative day. Secondary criteria address inflammation, haemorrhage, ischaemia, and pain. A follow-up phone call is given to the patients 30 days after their surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Short- and Medium-term Results of New Generation Aortic

NCT05055089

Echocardiography Aortic Valve Cardiac Surgery +1 more

UNKNOWN

Aortic Root Enlargement in Aortic Valve Replacement

NCT03603483

Aortic Valve Replacement

UNKNOWN NA

Fate at Long-term of Mild to Moderate Bicuspid Aortic Valve Disease Left Untreated at the Time of Supracoronary Ascending Aorta Replacement

NCT05836363

Bicuspid Aortic Valve Ascending Aorta Aneurysm

COMPLETED

Study of Treatment of Thoracic Aortic Aneurysms and Dilatation in Combination With Tricuspid and Bicuspid Aortic Valves.

NCT04372563

Ascending Aorta Aneurysm Dilation of the Ascending Aorta

RECRUITING

The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve Replacement

NCT01375335

Heart Failure

SUSPENDED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Replacement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Arnica 5CH and Bryonia 9CH (homeopathic drugs)

Group Type EXPERIMENTAL

Arnica and Bryonia

Intervention Type DRUG

Arnica 5CH granules, 5 per day plus Bryonia 5CH Granules, 5 per day for 5 days

2

placebo Arnica 5CH and Bryonia 9CH

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DRUG

5 placebo granules for Arnica 5 CH and 5 placebo granules for Bryonia 5 CH

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

placebo

5 placebo granules for Arnica 5 CH and 5 placebo granules for Bryonia 5 CH

Intervention Type DRUG

Arnica and Bryonia

Arnica 5CH granules, 5 per day plus Bryonia 5CH Granules, 5 per day for 5 days

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years, undergoing aortic valve surgery with extra corporeal circulation

Exclusion Criteria

* acute infectious or inflammatory concomitant disease, known allergy to one of the investigational products, Patients who did not sign the study consent form, patients having received during the 3 days before surgery any corticoids or non steroid anti-inflammatory drug, patient undergoing a surgery other than surgery of the aortic valve in the same intervention, patient undergoing an iterative cardiac surgery, patients under 18 years, patient over 18 years under the protection of the law.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No